• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. RUBY COIL; HCG, KRD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. RUBY COIL; HCG, KRD Back to Search Results
Model Number RBY4C0202-A
Medical Device Problem Code Physical Resistance/Sticking (4012)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/01/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
This device is available for return.A follow up mdr will be submitted upon completion of the device investigation.
 
Event or Problem Description
The patient was undergoing a coil embolization procedure using ruby coils and a non-penumbra microcatheter.During the procedure, while advancing a ruby coil through the microcatheter, the physician experienced resistance.Therefore, the ruby coil was removed.The procedure was completed using a new ruby coil.There was no report of an adverse effect to the patient.
 
Additional Manufacturer Narrative
Evaluation of the returned ruby coil pusher assembly revealed that the pet lock was separated, the pull wire was retracted, and the pusher assembly was kinked on its proximal end.This type of damage typically occurs during a detachment attempt.Further evaluation revealed that the embolization coil was detached from the pusher assembly and was not returned for evaluation.Based on the reported complaint, the observed damages may be incidental to the complaint.Due to the return damage, the root cause of resistance during the procedure could not be determined.Penumbra products are visually inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.Section h box 6.Conclusions code (4316): the investigation findings do not lead to a clear conclusion about the root cause of the reported complaint due to the return damage.H3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RUBY COIL
Common Device Name
HCG, KRD
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key12543815
Report Number3005168196-2021-02141
Device Sequence Number4102370
Product Code HCG
UDI-Device Identifier00814548013121
UDI-Public00814548013121
Combination Product (Y/N)Y
Initial Reporter CountrySN
PMA/510(K) Number
K120330
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/18/2022
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberRBY4C0202-A
Device Catalogue NumberRBY4C0202
Device Lot NumberF97332
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/02/2021
Supplement Date Received by Manufacturer04/04/2022
Initial Report FDA Received Date09/28/2021
Supplement Report FDA Received Date04/18/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/15/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
Date Report Sent to FDA01/01/2005
-
-